Jennifer Doudna. The CRISPR-Cas 9 Genome Engineering Revolution
Jennifer Doudna. The CRISPR-Cas 9 Genome Engineering Revolution
2016 Breakthrough Prize Symposium in Life Sciences
Session 2:
Genetic Origin and Manipulation of Disease
Chair:
Ehud Isacoff (UC Berkeley)
Featuring talks by:
1. Gary Ruvkun (Harvard University). The Tiny RNA World.
2. Jennifer Doudna (UC Berkeley). The CRISPR-Cas 9 Genome Engineering Revolution.
3. Napoleone Ferrara (UC San Diego). Targeting VEGF for Age-Related Macular Degeneration: A Case Study for Reduction in the Incidence of Blindness.
4. Robert Weinberg (MIT). The Engine Driving Malignant Progression.
The 2016 Breakthrough Prize Symposium is co-hosted by UC Berkeley, UC San Francisco, Stanford, and the Breakthrough Prize Foundation. This daylong event includes talks and panels featuring Breakthrough Prize laureates in Fundamental Physics, Life Sciences and Mathematics, as well as other distinguished guests. For more details on the day’s activities please visit: http://breakthroughprize.berkeley.edu/symposium
- CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
- CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
- The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
- The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
- ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
- The Dark Side of CRISPR – Scientific American
- ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
- Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
- DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
- CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
- Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
- Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
- New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
- After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
Leave a Reply
You must be logged in to post a comment.